- Home
- GDEN vs IMTX Comparison
GDEN vs IMTX Comparison
Compare GDEN & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEN
- IMTX
- Stock Information
- Founded
- GDEN 1998
- IMTX N/A
- Country
- GDEN United States
- IMTX Germany
- Employees
- GDEN N/A
- IMTX N/A
- Industry
- GDEN Services-Misc. Amusement & Recreation
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDEN Consumer Discretionary
- IMTX Health Care
- Exchange
- GDEN Nasdaq
- IMTX Nasdaq
- Market Cap
- GDEN 727.9M
- IMTX 653.9M
- IPO Year
- GDEN 1999
- IMTX N/A
- Fundamental
- Price
- GDEN $32.60
- IMTX $6.11
- Analyst Decision
- GDEN Buy
- IMTX Strong Buy
- Analyst Count
- GDEN 6
- IMTX 4
- Target Price
- GDEN $37.00
- IMTX $14.67
- AVG Volume (30 Days)
- GDEN 186.2K
- IMTX 637.2K
- Earning Date
- GDEN 08-07-2025
- IMTX 08-12-2025
- Dividend Yield
- GDEN 3.06%
- IMTX N/A
- EPS Growth
- GDEN N/A
- IMTX N/A
- EPS
- GDEN 0.39
- IMTX N/A
- Revenue
- GDEN $653,614,000.00
- IMTX $155,801,989.00
- Revenue This Year
- GDEN $1.48
- IMTX N/A
- Revenue Next Year
- GDEN $2.88
- IMTX $1.92
- P/E Ratio
- GDEN $84.10
- IMTX N/A
- Revenue Growth
- GDEN N/A
- IMTX 93.56
- 52 Week Low
- GDEN $22.66
- IMTX $3.30
- 52 Week High
- GDEN $35.49
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- GDEN 71.12
- IMTX 63.27
- Support Level
- GDEN $30.10
- IMTX $5.50
- Resistance Level
- GDEN $32.63
- IMTX $6.17
- Average True Range (ATR)
- GDEN 0.82
- IMTX 0.27
- MACD
- GDEN 0.24
- IMTX 0.03
- Stochastic Oscillator
- GDEN 89.15
- IMTX 93.62
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.